Terms: = Germ cell tumor AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Staging
97 results:
1. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
2. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
[TBL] [Abstract] [Full Text] [Related]
3. Gadolinium-based contrast media does not improve the staging of neuroblastoma image-defined risk factors at diagnosis.
Morin CE; Hasweh R; Anton C; Dillman JR; Orscheln E; Smith EA; Kotagal M; Weiss BD; Ouyang J; Zhang B; Trout AT; Towbin AJ
Pediatr Blood Cancer; 2024 Jan; 71(1):e30724. PubMed ID: 37845799
[TBL] [Abstract] [Full Text] [Related]
4. A novel clinical tool and risk stratification system for predicting the event-free survival of neuroblastoma patients: A TARGET-based study.
Li M; Duan X; Li C; You D; Liu L
Medicine (Baltimore); 2023 Sep; 102(38):e34925. PubMed ID: 37746942
[TBL] [Abstract] [Full Text] [Related]
5. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
[TBL] [Abstract] [Full Text] [Related]
6. Development and validation of a nomogram for predicting survival in intermediate- and high-risk neuroblastoma of the Children's Oncology Group risk stratification.
Feng L; Kan Y; Wang W; Wang C; Zhang H; Xie P; Yang J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16377-16390. PubMed ID: 37702807
[TBL] [Abstract] [Full Text] [Related]
7. The International Association for the Study of Lung Cancer Thymic Epithelial tumors staging Project: Proposal for a Stage Classification for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant tumors.
Ruffini E; Huang J; Cilento V; Goren E; Detterbeck F; Ahmad U; Appel S; Bille A; Boubia S; Brambilla C; Cangir AK; Falkson C; Fang W; Filosso PL; Giaccone G; Girard N; Guerrera F; Infante M; Kim DK; Lucchi M; Marino M; Marom EM; Nicholson AG; Okumura M; Rami-Porta R; Rimner A; Simone CB; Asamura H;
J Thorac Oncol; 2023 Dec; 18(12):1655-1671. PubMed ID: 37689391
[TBL] [Abstract] [Full Text] [Related]
8. Head and neck mucosal melanoma: radiological considerations and UK imaging guidelines.
Algudkar A; Harrington K; Kerawala C; Bagwan I; Ap Dafydd D
Oral Maxillofac Surg; 2024 Mar; 28(1):363-372. PubMed ID: 37020144
[TBL] [Abstract] [Full Text] [Related]
9. Neoadjuvant treatment for stage III and IV cutaneous melanoma.
Gorry C; McCullagh L; O'Donnell H; Barrett S; Schmitz S; Barry M; Curtin K; Beausang E; Barry R; Coyne I
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012974. PubMed ID: 36648215
[TBL] [Abstract] [Full Text] [Related]
10. C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment.
Liang Z; Pan L; Shi J; Zhang L
Sci Rep; 2022 Nov; 12(1):20460. PubMed ID: 36443341
[TBL] [Abstract] [Full Text] [Related]
11. Differences in sentinel lymph node biopsy utilization in eligible melanoma patients treated with Mohs micrographic surgery or wide local excision: A population-based logistic regression model and survival analysis.
Knackstedt TJ
J Am Acad Dermatol; 2023 Apr; 88(4):848-855. PubMed ID: 36368376
[TBL] [Abstract] [Full Text] [Related]
12. Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma.
Wang F; Zheng A; Zhang D; Zou T; Xiao M; Chen J; Wen B; Wen Q; Wu X; Li M; Du F; Chen Y; Zhao Y; Shen J; Xiang S; Li J; Deng S; Zhang Z; Yi T; Xiao Z
Front Immunol; 2022; 13():1024931. PubMed ID: 36341345
[TBL] [Abstract] [Full Text] [Related]
13. An
Feng L; Lu X; Yang X; Kan Y; Sun D; Wang W; Yang J
Eur J Radiol; 2022 Sep; 154():110444. PubMed ID: 35917754
[TBL] [Abstract] [Full Text] [Related]
14. A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma.
Hynes MC; Nguyen P; Groome PA; Asai Y; Mavor ME; Baetz TD; Hanna TP
BMC Cancer; 2022 Jul; 22(1):720. PubMed ID: 35778691
[TBL] [Abstract] [Full Text] [Related]
15. A novel nomogram and risk classification system predicting the Ewing sarcoma: a population-based study.
Zheng Y; Lu J; Shuai Z; Wu Z; Qian Y
Sci Rep; 2022 May; 12(1):8154. PubMed ID: 35581219
[TBL] [Abstract] [Full Text] [Related]
16. Inclusion of the Number of Metastatic Lymph Nodes in the staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer tumor-Node-Metastasis staging System.
Wang Z; Tang C; Wang Y; Yin Z; Rixiati Y
Thyroid; 2022 May; 32(5):536-543. PubMed ID: 35350868
[No Abstract] [Full Text] [Related]
17. Association of Lymph Node Count and Survival after Primary Retroperitoneal Lymphadenectomy for Nonseminomatous Testicular Cancer.
Patel HV; Srivastava A; Kim S; Patel HD; Pierorazio PM; Bagrodia A; Masterson TA; Ghodoussipour SB; Kim IY; Singer EA; Jang TL
J Urol; 2022 May; 207(5):1057-1066. PubMed ID: 34978466
[TBL] [Abstract] [Full Text] [Related]
18. Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal Melanoma.
Gelmi MC; Bas Z; Malkani K; Ganguly A; Shields CL; Jager MJ
Ophthalmology; 2022 Apr; 129(4):431-437. PubMed ID: 34793831
[TBL] [Abstract] [Full Text] [Related]
19. Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).
Lau PKH; Feran B; Smith L; Lasocki A; Molania R; Smith K; Weppler A; Angel C; Kee D; Bhave P; Lee B; Young RJ; Iravani A; Yeang HA; Vergara IA; Kok D; Drummond K; Neeson PJ; Sheppard KE; Papenfuss T; Solomon BJ; Sandhu S; McArthur GA
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625515
[TBL] [Abstract] [Full Text] [Related]
20. Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning.
Yang CQ; Wang H; Liu Z; Hueman MT; Bhaskaran A; Henson DE; Sheng L; Chen D
PLoS One; 2021; 16(9):e0257949. PubMed ID: 34591891
[TBL] [Abstract] [Full Text] [Related]
[Next]
